Clover Health Investments, Corp. /De financial data

Symbol
CLOV on Nasdaq
Location
3401 Mallory Lane, Suite 210, Franklin, TN
State of incorporation
DE
Fiscal year end
December 31
Former names
Social Capital Hedosophia Holdings Corp. III (to 1/7/2021)
Latest financial report
10-Q - Q3 2024 - Nov 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 161 % +29.1%
Debt-to-equity 293 % +26.2%
Return On Equity -29.3 % +57%
Return On Assets -14.2 % +54.1%
Operating Margin -4.28 % +68.3%

Shares

Label TTM Value / Value Unit Change %
Entity Public Float 360M USD -57.1%
Weighted Average Number of Shares Outstanding, Basic 490M shares +1.96%
Weighted Average Number of Shares Outstanding, Diluted 490M shares +1.96%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 2.12B USD +14.8%
General and Administrative Expense 171M USD -12.4%
Operating Income (Loss) -90.6M USD +63.7%
Net Income (Loss) Attributable to Parent -91.4M USD +59.8%
Earnings Per Share, Basic -0.44 USD/shares +38%
Earnings Per Share, Diluted -0.44 USD/shares +38%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 288M USD -3.7%
Other Assets, Current 2.8M USD +171%
Assets, Current 433M USD -52.7%
Property, Plant and Equipment, Net 5.34M USD +16.7%
Operating Lease, Right-of-Use Asset 2.59M USD -28.6%
Goodwill 0 USD -100%
Other Assets, Noncurrent 11M USD -24.3%
Assets 653M USD -4.67%
Contract with Customer, Liability, Current 17K USD -100%
Liabilities, Current 280M USD -61.1%
Operating Lease, Liability, Noncurrent 2.32M USD -29.5%
Other Liabilities, Noncurrent 28.9M USD +81.1%
Liabilities 311M USD -57.9%
Accumulated Other Comprehensive Income (Loss), Net of Tax 852K USD
Retained Earnings (Accumulated Deficit) -2.18B USD -4.37%
Stockholders' Equity Attributable to Parent 323M USD -34%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 342M USD +6.31%
Liabilities and Equity 653M USD -38.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 25.9M USD -67.2%
Net Cash Provided by (Used in) Financing Activities -3.36M USD -57.4%
Net Cash Provided by (Used in) Investing Activities 9.19M USD -9.78%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 31.8M USD -63.5%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 288M USD -18.1%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD -100%
Deferred Tax Assets, Valuation Allowance 397M USD +7.41%
Deferred Tax Assets, Gross 399M USD +7.04%
Operating Lease, Liability 4.66M USD -20.4%
Payments to Acquire Property, Plant, and Equipment 445K USD +77.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -85.5M USD +61.4%
Lessee, Operating Lease, Liability, to be Paid 5.65M USD -23.2%
Property, Plant and Equipment, Gross 9.67M USD +19.9%
Operating Lease, Liability, Current 1.35M USD -19.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.27M USD -19.3%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.74M USD -8.92%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 987K USD -34.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.16M USD -6.4%
Deferred Tax Assets, Operating Loss Carryforwards 320M USD +8.86%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 25M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.19M USD +3.03%
Additional Paid in Capital 2.55B USD +4.86%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 1.64M USD -41.8%
Share-based Payment Arrangement, Expense 141M USD -14.2%
Interest Expense 7K USD -99.5%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%